Red List

CELCCelcuity Inc.

Healthcare · Biotechnology · mid-cap ($4.5B)
-30.8%
from rolling 252-day high of $151.02 set 2026-05-04 · 58d ago
Current
$104.49
Decline depth
-30.8%
Decline σ
1.3σ
TFC
2/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$CELC landed on the list 2026-06-02, down 39.5% from its 52-week high that day — now down -30.8%.

It has clawed back 11.0 percentage points off that level. It bottomed 42.2% below that high along the way.

Decline from the 52-week high as it stood on 2026-06-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

CELC qualifies for the Red List on decline depth.

Decline depth
-30.8%
From rolling 252-day high of $151.02, 58d ago. Past the 30% Amber threshold.
Time-frame continuity
2/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
1.3σ
Drop from local high over the last 5 bars, expressed in units of the stock's typical daily volatility (3.06% per day).

The structural read

What price action says about CELC.

CELC qualifies for the Red List on decline depth — down -30.8% from its rolling 252-day high. Past 30% with the high set inside the last four months — the recency clause that often precedes further breakdown. Depth plus recency: this is the pattern many investors call a falling knife.

Earnings on file: 2026-05-14. Tiering is unaffected by earnings dates — listings reflect price structure only.

52-week range

52W low $11.28 66.7% of range 52W high $151.02

Sector context · Healthcare

153 other Healthcare tickers are on Broken Stocks.

70 Red List
32 Amber
51 Watch
-34.6% Median decline

Worst in sector: UPB (-78.4%). Least-bad: TMO (-20.1%). See all Healthcare listings →

Questions about CELC

What people ask.

Why is CELC on Broken Stocks?

CELC qualifies for the Red List on decline depth. It is down -30.8% from its rolling 252-day high of $151.02, set on 2026-05-04 — 58d ago.

Is CELC a falling knife?

By the most common technical definition — a steep, recent breakdown from a fresh high — yes. CELC is down -30.8% from its 52-week high of $151.02, set 58d ago. That combination of depth (past the 30% Amber threshold) and recency (high set inside the last 120 days) is the textbook falling-knife pattern. Whether to try to catch it is a separate question — historically most attempts to bottom-pick continue lower before reversing. Broken Stocks flags the pattern; it does not recommend buying or selling.

Is CELC a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is CELC trading inside its 52-week range?

At $104.49, CELC sits 66.7% of the way from its 52-week low ($11.28) to its 52-week high ($151.02). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has CELC been declining?

The current 30.8% decline accrued over 58d, which annualizes to roughly -193.8% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does CELC compare to its sector?

There are 153 other Healthcare tickers on Broken Stocks: 70 Red, 32 Amber, 51 Watch, with 70 showing recovering structural signals. Median sector decline is -34.6% — CELC's decline is shallower than the sector median.

Does CELC's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-14) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.